60
BioIntelliSense, Inc. raises $58.1M under Reg D
Company raise · Raising · Offering $58.4M · Sold $58.1M · GOLDEN, CO · filed 2025-12-19
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Earlier and related filings by the same issuer and sponsor.
| Conlan Ma | Director |
| David Wang | Executive Officer, Director |
| Xinyaun Yu | Director |
| James Mault | Executive Officer, Director |
Signed by David Wang, Chief Executive Officer.
Relevant to: B2B software & services sales.
The issuer's phone number and address from the filing are shown to subscribers. See plans.